Recent framework agreements between the United States and Iran, including a June 2026 memorandum of understanding on ceasefire extension, Strait of Hormuz access, and sanctions relief, have placed congressional review under the Iran Nuclear Agreement Review Act at the center of trader assessments. President Trump has signaled openness to submitting details to lawmakers for approval, yet Republicans and Democrats have both expressed skepticism over verification terms, uranium enrichment limits, and the durability of any nuclear commitments. Bipartisan letters demanding stricter conditions on enrichment and missile issues, combined with the 60-day timeline for follow-on nuclear talks, create balanced uncertainty around passage. Outcomes hinge on the substance of finalized texts, Senate vote thresholds, and any late shifts in administration priorities before year-end.